A New Class of Peroxisome Proliferator-activated Receptor Agonists with a Novel Binding Epitope Shows Antidiabetic Effects
Open Access
- 1 September 2004
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (39) , 41124-41130
- https://doi.org/10.1074/jbc.m401552200
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- A Unique PPARγ Ligand with Potent Insulin-Sensitizing yet Weak Adipogenic ActivityMolecular Cell, 2001
- Fenofibrate and Rosiglitazone Lower Serum Triglycerides with Opposing Effects on Body WeightBiochemical and Biophysical Research Communications, 2000
- Ligand-induced stabilization of PPARγ monitored by NMR spectroscopy: implications for nuclear receptor activationJournal of Molecular Biology, 2000
- A Ureido-Thioisobutyric Acid (GW9578) Is a Subtype-Selective PPARα Agonist with Potent Lipid-Lowering ActivityJournal of Medicinal Chemistry, 1999
- [20] Processing of X-ray diffraction data collected in oscillation modePublished by Elsevier ,1997
- 15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγCell, 1995
- AMoRe: an automated package for molecular replacementActa Crystallographica Section A Foundations of Crystallography, 1994
- The peroxisome proliferator-activated receptor:retinoid X receptor heterodimer is activated by fatty acids and fibrate hypolipidaemic drugsJournal of Molecular Endocrinology, 1993
- Positive regulation of the peroxisomal β‐oxidation pathway by fatty acids through activation of peroxisome proliferator‐activated receptors (PPAR)Biology of the Cell, 1993
- Improved methods for building protein models in electron density maps and the location of errors in these modelsActa Crystallographica Section A Foundations of Crystallography, 1991